EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

NCT03594110 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6609

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Empagliflozin
DRUG: Matching placebo

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]
[object Object]